Skip to content
healthcare.dev
Get a free key

EBGLYSS

NDC 0002-7772, lebrikizumab-lbkz, injection, solution, from Eli Lilly and Company.

Product NDC
0002-7772
Status
Listed
Labeler
Eli Lilly and Company
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761306
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0002-7772 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LEBRIKIZUMAB250 mg/2mL

Pharmacologic classes

Interleukin-13 Antagonist [EPC]; Interleukin-13 Antagonists [MoA]

Package NDCNDC-11Package
0002-7772-11000027772111 SYRINGE in 1 CARTON (0002-7772-11) / 2 mL in 1 SYRINGE (0002-7772-01)
0002-7772-62000027772622 SYRINGE in 1 CARTON (0002-7772-62) / 2 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7a774ea2-acde-4aaa-9a8f-ccba5a5b1d5f

  • NADAC price for package 00002777211

    GET /v1/drugs/nadac/00002777211

Use it

Look up 0002-7772 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0002-7772 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0002-7772. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.